Formulation: A neat solid

Purity: ≥98%

Schedule: II

• D-Desoxyephedrine
• D-Methamphetamine
• (+)-Methylamphetamine
• NSC 169505

Formulation: A neat solid

Purity: ≥98%

Schedule: I

• 3,4-Methylenedioxymethylamphetamine
• NSC 168383

Formulation: A crystalline solid

Purity: ≥98%

• 2,5-dimethoxy-4-Iodoamphetamine

Formulation: A solution in acetonitrile (1 mg/ml of each compound)

Formulation: A crystalline solid

Purity: ≥98%

Schedule: IV

• CEP-1538
• CRL 40476
• (±)-Modafinil

Formulation: A neat solid

Purity: ≥98%

Schedule: III

• 4-Androstene-3,17-dione
• Fecundin
• NSC 9563
• SKF 2170

Formulation: A crystalline solid

Purity: ≥97%

Schedule: III

• Androstanolone
• DHT
• NSC 10972
• Stanolone

Formulation: A neat solid

Purity: ≥98%

Schedule: II

• L-Lysine-Dextroamphetamine

Formulation: A neat solid

Purity: ≥98%

Schedule: II

• DL-Methamphetamine
• NSC 22367
• NSC 169506

Formulation: A crystalline solid

Purity: ≥98%

Schedule: IV

• (+)-Cathine
• (+)-Norpseudoephedrine
• D-Norpseudoephedrine

Formulation: A crystalline solid

Purity: ≥98%

• 5-(2-Methylaminopropyl)Benzofuran

Formulation: A 1 mg/ml solution in methanol

Formulation: A crystalline solid

Purity: ≥95%

• N-Methyl-1,3-Benzodioxolylbutanamine

Formulation: A neat solid

Purity: ≥98%

Schedule: I

• Eve
• MDE
• 3,4-Methylenedioxyethylamphetamine

Formulation: A neat solid

Purity: ≥98%

Schedule: I

• 3,4-MDA
• 3,4-Methylenedioxyamphetamine
• NSC 9978
• NSC 27106

Formulation: A crystalline solid

Purity: ≥95%

• 5-(2-Aminopropyl)Benzofuran

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• 2,5-Dimethoxy-4-methylamphetamine
• STP

Formulation: A crystalline solid

Purity: ≥98%

• NPA
• α-methyl-N-propyl-Benzeneethanamine

Formulation: A crystalline solid

Purity: ≥98%

Schedule: II

• Dextroamphetamine
• (+)-α-Methylphenethylamine
• NSC 27104

Formulation: A crystalline solid

Purity: ≥98%

• 6-(2-Aminopropyl)Benzofuran
• Benzo Fury

Formulation: A crystalline solid

Purity: ≥98%

Schedule: Listed

• (+)-EPH
• D-Ephedrine
• (1S,2R)-(+)-Ephedrine

Formulation: A crystalline solid

Purity: ≥98%

• 2,5-Dimethoxy-4-chloroamphetamine
• 4-chloro-2,5-Dimethoxyamphetamine
• DOC

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• Ritalinic Acid ethyl ester

Formulation: A crystalline solid

Purity: ≥98%

• 6-(2-Methylaminopropyl)Benzofuran

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• 4-FA
• p-FA